Detailed information for compound 187029

Basic information

Technical information
  • TDR Targets ID: 187029
  • Name: 7-bromo-N-cyclopropyl-1,1-dioxo-4H-benzo[e][1 ,2,4]thiadiazin-3-amine
  • MW: 316.174 | Formula: C10H10BrN3O2S
  • H donors: 2 H acceptors: 2 LogP: 1.45 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: Brc1ccc2c(c1)S(=O)(=O)NC(=N2)NC1CC1
  • InChi: 1S/C10H10BrN3O2S/c11-6-1-4-8-9(5-6)17(15,16)14-10(13-8)12-7-2-3-7/h1,4-5,7H,2-3H2,(H2,12,13,14)
  • InChiKey: ZXKNAOOLJSSKRL-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • (7-bromo-1,1-diketo-4H-benzo[e][1,2,4]thiadiazin-3-yl)-cyclopropyl-amine

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium ulcerans fructose-2,6-bisphosphatase GpmB 0.1261 0.5631 0.5
Giardia lamblia Hypothetical protein 0.1261 0.5631 0.5
Schistosoma mansoni 6-phosphofructokinase 0.2136 1 1
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.21 0.982 0.9706
Giardia lamblia Hypothetical protein 0.1261 0.5631 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.2136 1 1
Loa Loa (eye worm) hypothetical protein 0.2136 1 1
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.21 0.982 0.9706
Onchocerca volvulus 0.2136 1 0.5
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.2136 1 1
Trypanosoma brucei 6-phosphofructo-2-kinase 2 0.21 0.982 0.9706
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.21 0.982 0.9706
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.2136 1 1
Loa Loa (eye worm) hypothetical protein 0.21 0.982 0.9604
Echinococcus multilocularis 6 phosphofructo 2 kinase:fructose 2 0.2136 1 1
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.1261 0.5631 0.5
Mycobacterium ulcerans hypothetical protein 0.1261 0.5631 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.2136 1 1

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) = 89.4 uM Effective dose required for relaxation of the 30 mM KCl-induced contraction of rat aortic rings ChEMBL. 12852765
IC50 (functional) = 3.1 uM Concentration required to inhibit insulin release in rat ChEMBL. 12852765
ND (functional) 0 Inhibition of residual insulin release from rat pancreatic islets in the presence of 16.7mM glucose at 0.1 microM concentration; Not determined ChEMBL. 12852765
RIS (functional) = 4.6 % Percent inhibition of residual insulin release from rat pancreatic islets in the presence of 16.7mM glucose at 50 microM concentration ChEMBL. 12852765
RIS (functional) = 21.1 % Percent inhibition of residual insulin release from rat pancreatic islets in the presence of 16.7mM glucose at 10 microM concentration ChEMBL. 12852765
RIS (functional) = 85.1 % Percent inhibition of residual insulin release from rat pancreatic islets in the presence of 16.7mM glucose at 1 microM concentration ChEMBL. 12852765
Selectivity (functional) = 29 Estimated selectivity ratio of ED50 and IC50 in rat was calculated ChEMBL. 12852765

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.